Synthesis and Biological Evaluation of a Multiantigenic Tn/TF‐Containing Glycopeptide Mimic of the Tumor‐Related MUC1 Glycoprotein

No abstract is available for this paper.

• Publication year

  2006

• Venue

  ChemMedChem

• Publication date

  2006-09-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.200600104PMID 16952141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combining a polar resin and a pseudo‐proline to optimize the solid‐phase synthesis of a ‘difficult sequence’

  2006cited by this paper
• Eine vollsynthetische Vakzine aus einem tumorassoziierten Glycopeptid‐Antigen und einem T‐Zell‐Epitop zur Induktion einer hochspezifischen humoralen Immunantwort

  2005cited by this paper
• Chemical synthesis of 23 kDa glycoprotein by repetitive segment condensation: a synthesis of MUC2 basal motif carrying multiple O-GalNAc moieties.

  2005cited by this paper
• A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.

  2005cited by this paper
• Towards a fully synthetic carbohydrate-based anticancer vaccine: synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated tn antigen.

  2005cited by this paper
• Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn

  2005cited by this paper
• Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

  2005cited by this paper
• Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and bovine serum albumin.

  2005cited by this paper
• MUC1 and the MUCs: A Family of Human Mucins with Impact in Cancer Biology

  2004cited by this paper
• A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

  2004cited by this paper
• Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines.

  2004cited by this paper
• Synthesis of branched oxime-linked peptide mimetics of the MUC1 containing a universal T-helper epitope.

  2004cited by this paper
• Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.

  2004cited by this paper
• MUC1 immunobiology: from discovery to clinical applications.

  2004cited by this paper
• Modular assembly of glycoproteins: towards the synthesis of GlyCAM-1 by using expressed protein ligation.

  2004cited by this paper
• Influence of polar support for the synthesis of large C-terminal peptide aldehyde: application to chemoselective ligation

  2002cited by this paper
• Synthesis of glycoproteins.

  2002cited by this paper
• Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain.

  2001cited by this paper
• Synthesis of glycopeptides containing carbohydrate and Peptide recognition motifs.

  2000cited by this paper
• Identification of by-products from an orthogonal peptide ligation by oxime bonds using mass spectrometry and tandem mass spectrometry.

  2000cited by this paper
• A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.

  1999cited by this paper
• Pseudo-Prolines as a Solubilizing, Structure-Disrupting Protection Technique in Peptide Synthesis

  1996cited by this paper
• Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines:

  1996cited by this paper
• Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

  1994cited by this paper
• 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive

  1993cited by this paper
• Site-directed conjugation of nonpeptide groups to peptides and proteins via periodate oxidation of a 2-amino alcohol. Application to modification at N-terminal serine.

  1992cited by this paper
• Production of MUC1 and MUC2 mucins by human tumor cell lines.

  1991cited by this paper
• Methodological implications of simultaneous solid-phase peptide synthesis. 1. Comparison of different coupling procedures

  1988cited by this paper
• O-Benzotriazolyl-N,N,N′,N′-tetramethyluronium Hexafluorophosphate as Coupling Reagent for the Synthesis of Peptides of Biological Interest

  1984cited by this paper
• p-alkoxybenzyl alcohol resin and p-alkoxybenzyloxycarbonylhydrazide resin for solid phase synthesis of protected peptide fragments.

  1973cited by this paper

• Carrier diversity and chemical ligations in the toolbox for designing tumor-associated carbohydrate antigens (TACAs) as synthetic vaccine candidates.

  2023cites this paper
• Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.

  2022cites this paper
• Recent advances on smart glycoconjugate vaccines in infections and cancer

  2021cites this paper
• Synthetic carbohydrate-based vaccines: challenges and opportunities

  2020cites this paper
• Carbohydrate‐based vaccines for oncotherapy

  2018cites this paper
• Synthesis of a Self-Adjuvanting MUC1 Vaccine via Diselenide-Selenoester Ligation-Deselenization.

  2018cites this paper
• Design, Synthesis, and Immunological Evaluation of a Multicomponent Construct Based on a Glycotripeptoid Core Comprising B and T Cell Epitopes and a Toll-like Receptor 7 Agonist That Elicits Potent Immune Responses.

  2018cites this paper
• CD4 T Cells in Antitumor Immunity

  2016cites this paper
• Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues† †Electronic supplementary information (ESI) available: Detailed synthetic procedures, characterization and optimization. See DOI: 10.1039/c5sc00773a

  2015cites this paper
• Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer

  2015cites this paper
• Eine vollsynthetische Vier-Komponenten-Antitumor-Vakzine mit einem MUC1-Glycopeptid und drei verschiedenen T-Helferzell- Epitopen†

  2014cites this paper
• Conjugation Strategies Used for the Preparation of Carbohydrate‐Conjugate Vaccines

  2014cites this paper
• A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.

  2014cites this paper
• Oxime ligation: a chemoselective click-type reaction for accessing multifunctional biomolecular constructs.

  2014cites this paper
• Solid phase oxime ligations for the iterative synthesis of polypeptide conjugates.

  2014cites this paper
• The development of synthetic antitumour vaccines from mucin glycopeptide antigens.

  2013cites this paper
• Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid.

  2013cites this paper
• Synthetically defined glycoprotein vaccines: current status and future directions

  2013cites this paper
• Multivalent glyco(cyclo)peptides.

  2013cites this paper
• Convergent synthesis of MUC1 glycopeptides via serine ligation.

  2013cites this paper
• Chemical synthesis of carbohydrate-based vaccines against cancers

  2013cites this paper
• MUC1‐Glycopeptidkonjugate mit T‐Zellepitopen von Tetanus‐Toxoid als vollsynthetische Antitumor‐Vakzine mit Eigenverstärkungseffekt

  2013cites this paper
• Synthesis of multi-antigenic platforms as vaccine candidates against cancers

  2013cites this paper
• Carbohydrate-based cancer vaccines: target cancer with sugar bullets

  2012cites this paper
• Antibody recognition of fluorinated MUC1 glycopeptide antigens.

  2012cites this paper
• Synthesis and analytical investigation of C‐terminally modified peptide aldehydes and ketone: application to oxime ligation

  2012cites this paper
• Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.

  2012cites this paper
• [Recent advance in carbohydrate-based cancer vaccines].

  2012cites this paper
• Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway.

  2012cites this paper
• Glycodendrimers as functional antigens and antitumor vaccines

  2012cites this paper
• Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma

  2012cites this paper
• Synthesis and immunological evaluation of self-assembling and self-adjuvanting tricomponent glycopeptide cancer-vaccine candidates.

  2012cites this paper
• Engineering O-glycosylation points in non-extended peptides: implications for the molecular recognition of short tumor-associated glycopeptides.

  2011cites this paper
• Investigation of in-source decay of oxime-linked peptide by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2011cites this paper
• Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation

  2011cites this paper
• Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

  2011cites this paper
• Carbohydrate-based vaccines: challenges and opportunities

  2010cites this paper
• Synthesis of MUC1-lipopeptide chimeras.

  2010cites this paper
• La multi-ligation triazole : développement de nouveaux outils pour la synthèse de mimes de protéines par cycloadditions successives

  2010cites this paper
• Development, Characterization, and Immunotherapeutic Use of Peptide Mimics of the Thomsen-Friedenreich

  2009cites this paper
• Biomolecular assembly by iterative oxime ligations.

  2009cites this paper
• Immunotherapy for cancer: synthetic carbohydrate-based vaccines.

  2009cites this paper
• Induction of a Melanoma‐Specific Antibody Response by a Monovalent, but not a Divalent, Synthetic GM2 Neoglycopeptide

  2009cites this paper
• Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.

  2009cites this paper
• Ligation chimique sur support solide : vers la préparation d'analogues de la glycoprotéine MUC1

  2008cites this paper
• Efficient sequential segment coupling using N-alkylcysteine-assisted thioesterification for glycopeptide dendrimer synthesis.

  2008cites this paper
• Synthetische Vakzine aus tumorassoziierten Glycopeptidantigenen durch immunkompatible Verankerung über Thioether an Rinderserumalbumin

  2007cites this paper
• Synthetic glycopeptides for the development of cancer vaccines.

  2007cites this paper
• Synergic effect of hydride and proton donors in the Pd(0)-mediated deprotection of Nα-Aloc proline derivatives

  2007cites this paper
• Efficient Enzymatic Glycosylation of Peptides and Oligosaccharides from GalNAc and UTP

  2007cites this paper
• Synthetic vaccines of tumor-associated glycopeptide antigens by immune-compatible thioether linkage to bovine serum albumin.

  2007cites this paper
• DÉVELOPEMENT D'UN SYSTÈME DE RÉGÉNÉRATION D'UDP-GA1NAC POUR LA GLYCOSYLATION ENZYMATIQUE D'OLIGOSACCHARIDES ET DE PEPTIDES D'INTÉRÊT THÉRAPEUTIQUE

  2006cites this paper